Pentagon's Testosterone Testing Decision for US Soldiers Challenged by Health Experts

A recent decision by U.S. Secretary of Defense Pete Hegseth to introduce annual testosterone testing for active-duty military personnel and reservists over 30 years old has ignited a debate within the medical community. The new directive mandates yearly checks for low testosterone levels but does not compel treatment if levels are found to be low.

Hegseth argues that the measure aims to boost soldiers' physical endurance, performance, and combat readiness. He maintains that decisions regarding treatment will remain voluntary and made in consultation with medical professionals. However, this rationale is being challenged by a significant portion of the health sector.

Reuters consulted six male health experts, five of whom expressed skepticism about the justification for routine testing across all military personnel over 30. They cautioned that such a broad approach could lead to unnecessary or even harmful treatments. Current guidelines from the American Urological Association and the Endocrine Society suggest testosterone therapy should be reserved for patients with confirmed low hormone levels coupled with symptoms like decreased libido, erectile dysfunction, persistent fatigue, reduced muscle mass, or bone density loss.

“

The measure will contribute to increasing the physical resistance, performance, and combat readiness of the military personnel, and the decision regarding treatment will remain voluntary and will be made together with doctors.

Medical professionals emphasize that testosterone levels naturally decline with age, typically after 30 or 40, but this process varies individually. They argue that this natural aging process alone does not warrant systematic testing of the entire military population. Furthermore, specialists highlight the risks associated with administering treatment without clear medical indications. These potential adverse effects include infertility, testicular shrinkage, blood thickening, cardiac rhythm disturbances, bone fractures, prostate issues, acne, hair loss, breast tissue development, and mood changes.

The Pentagon also aims to detect what is termed "Operator Syndrome," a condition reportedly affecting special forces personnel with symptoms including low testosterone, traumatic brain injuries, hormonal and metabolic disorders, and sleep problems. However, some experts believe this syndrome is specific to soldiers exposed to extreme combat conditions and cannot be generalized to all military personnel. They suggest that in many cases, testosterone levels may be affected by factors other than a simple deficiency requiring treatment.

“

five of the six male health experts consulted by Reuters stated that they do not understand the justification for routine testing for all military personnel over 30 years of age and warn that it could lead to unnecessary or even harmful treatments.